1. Sun, Yonghong, Chen, Xingxing, Chen, Lili, Li, Chunming, Zhou, Yongning. 2023. MFAP2 promotes HSCs activation through FBN1/TGF-β/Smad3 pathway. In Journal of cellular and molecular medicine, 27, 3235-3246. doi:10.1111/jcmm.17884. https://pubmed.ncbi.nlm.nih.gov/37635348/
2. Huang, Jing, Xu, Yuting, Qi, Shengnan, Liu, Lei, Liu, Fan. 2024. The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer. In Discover oncology, 15, 202. doi:10.1007/s12672-024-01044-7. https://pubmed.ncbi.nlm.nih.gov/38822944/
3. Xue, Meng, Mi, Shuyi, Zhang, Zizhen, Wei, Wei, Lou, Guochun. 2022. MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3. In Cancer medicine, 12, 8403-8414. doi:10.1002/cam4.5561. https://pubmed.ncbi.nlm.nih.gov/36583532/
4. Yu, Jingjing, Wang, Fengbo, Dong, Rui, Jia, Wei. 2024. The use of MFAP2 for diagnosis, prognosis and immunotherapy of triple-negative breast cancer. In American journal of translational research, 16, 1322-1336. doi:10.62347/BLDG4505. https://pubmed.ncbi.nlm.nih.gov/38715831/
5. Li, Meng, Zhang, Hong-Yi, Zhang, Rong-Gui. 2023. MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy. In PeerJ, 11, e15441. doi:10.7717/peerj.15441. https://pubmed.ncbi.nlm.nih.gov/37304872/
6. Zhao, Ling-Qin, Sun, Wei, Zhang, Ping, Fang, Chen-Yan, Zheng, Ai-Wen. 2022. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer. In The Kaohsiung journal of medical sciences, 38, 772-780. doi:10.1002/kjm2.12546. https://pubmed.ncbi.nlm.nih.gov/35546486/
7. Yao, Li-Wen, Wu, Lian-Lian, Zhang, Li-Hui, Yang, Yan-Ning, Yu, Hong-Gang. 2020. MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway. In Oncogenesis, 9, 17. doi:10.1038/s41389-020-0198-z. https://pubmed.ncbi.nlm.nih.gov/32054827/
8. Dong, Si Yang, Chen, Hao, Lin, Li Zhi, Wang, Ou Chen, Ye, Zhi Qiang. 2020. MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer. In Cancer management and research, 12, 12557-12567. doi:10.2147/CMAR.S274986. https://pubmed.ncbi.nlm.nih.gov/33324100/
智鼠故事 
